The UK became the first western country to approve a Covid-19 vaccine with its regulator clearing Pfizer Inc. and BioNTech SE’s shot ahead of decisions in the US and European Union. The emergency authorisation clears the way for the deployment of a vaccine that’s expected to play a significant role in the global effort to halt the coronavirus. Pfizer and its German partner said in November that the shot, relying on novel technology called messenger RNA, was 95% effective in a final analysis of clinical-trial data. Subscribe for full access to all our share and unit trust data tools, our award-winning articles, and support quality journalism in the process. You will be redirected to a checkout page.
To view all features and options, click here. A monthly subscription is charged pro rata, based on the day of purchase. This is non-refundable and includes a R5 once-off sign-up fee.
A yearly subscription is refundable within 14 days of purchase and includes a 365-day membership. The vaccine will be available in Britain from next week, according to a statement from the UK government. The UK had signaled it would move swiftly in approving a vaccine as part of an operation to protect its population, and doctors across the country were put on standby for a possible rollout. For the government, it’s an opportunity to make up for missteps during the pandemic as Britain’s death toll nears 60,000.